SCHEMBL8034384

SCHEMBL8034384

O=[C]OCOC(=O)C1CCCO1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.39
KDM4E B2RXH2 5/20 0.39
HSD17B10 Q99714 4/20 0.39
NPSR1 Q6W5P4 2/20 0.37
LMNA P02545 2/20 0.37
HPGD P15428 6/20 0.37
TSHR P16473 2/20 0.37
NOS2 P35228 1/20 0.35
POLB P06746 3/20 0.35
RAB9A P51151 3/20 0.35
NPC1 O15118 2/20 0.35
TP53 P04637 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
MAPT P10636 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.33
TDP1 Q9NUW8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20599622 0.77 ALDH1A1 (0.43) ALDH1A1KDM4EHSD17B10NPSR1LMNA
SCHEMBL5384353 0.75 ALDH1A1 (0.42) ALDH1A1KDM4EHSD17B10NPSR1LMNA
SCHEMBL1813924 0.75 HPGD (0.50) ALDH1A1KDM4EHSD17B10NPSR1LMNA
SCHEMBL22356176 0.75 NOS2 (0.44) ALDH1A1KDM4EHSD17B10NPSR1LMNA
SCHEMBL8626242 0.75 HPGD (0.50) ALDH1A1KDM4EHSD17B10NPSR1LMNA
SCHEMBL8627456 0.75 HPGD (0.50) ALDH1A1KDM4EHSD17B10NPSR1LMNA
SCHEMBL22356162 0.75 NOS2 (0.44) ALDH1A1KDM4EHSD17B10NPSR1LMNA
SCHEMBL22480301 0.74 ALDH1A1 (0.41) ALDH1A1KDM4EHSD17B10NPSR1LMNA
SCHEMBL845360 0.73 ALDH1A1 (0.40) ALDH1A1TSHRMAPTSMN1; SMN2TDP1
SCHEMBL17361182 0.72 ALDH1A1 (0.52) ALDH1A1KDM4EHSD17B10NPSR1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6057324-A HAVE GPIIB/IIIA RECEPTOR ANTAGONIZING ACTIVITY AND ARE USEFUL FOR AMELIORATING ISCHEMIC CARDIAC DISORDERS, FOR AMELIORATING CEREBROVASCULAR DISORDERS, AND FOR AMELIORATING PERIPHERAL ARTERY DISORDERS YAMANOUCHI PHARMACEUTICAL CO., LTD (JP) 2000-05-02 US claimed
EP-0905129-A1 SUBSTITUTED AMIDINOBENZENE DERIVATIVES AND MEDICINAL COMPOSITIONS THEREOF YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) 1999-03-31 EP claimed
US-6057324-A HAVE GPIIB/IIIA RECEPTOR ANTAGONIZING ACTIVITY AND ARE USEFUL FOR AMELIORATING ISCHEMIC CARDIAC DISORDERS, FOR AMELIORATING CEREBROVASCULAR DISORDERS, AND FOR AMELIORATING PERIPHERAL ARTERY DISORDERS YAMANOUCHI PHARMACEUTICAL CO., LTD (JP) 2000-05-02 US disclosed
EP-0905129-A1 SUBSTITUTED AMIDINOBENZENE DERIVATIVES AND MEDICINAL COMPOSITIONS THEREOF YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) 1999-03-31 EP disclosed